Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C29H50O |
| Molecular Weight | 414.7067 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 9 / 9 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C
InChI
InChIKey=KZJWDPNRJALLNS-VJSFXXLFSA-N
InChI=1S/C29H50O/c1-7-21(19(2)3)9-8-20(4)25-12-13-26-24-11-10-22-18-23(30)14-16-28(22,5)27(24)15-17-29(25,26)6/h10,19-21,23-27,30H,7-9,11-18H2,1-6H3/t20-,21-,23+,24+,25-,26+,27+,28+,29-/m1/s1
| Molecular Formula | C29H50O |
| Molecular Weight | 414.7067 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 9 / 9 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Beta-sitosterol is one of the main dietary phytosterols found in plants which have a similar skeleton as cholesterol. In human clinical trials, beta-sitosterol has been shown to have cholesterol-lowering effects and to relieve symptoms of benign prostatic hyperplasia. There has been a large amount of basic research conducted for potential applications of beta-sitosterol in a diverse range of conditions including cervical cancer, breast cancer, cystic fibrosis, and others. Beta-sitosterol is available over the counter as a natural health supplement and is marketed for a wide range of applications including headaches, tuberculosis, allergies, cancers, fibromyalgia, lupus, asthma, hair loss and many others.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P42574 Gene ID: 836.0 Gene Symbol: CASP3 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/12579296 |
|||
Target ID: P17252 Gene ID: 5578.0 Gene Symbol: PRKCA Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/28553226 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effect of β-sitosterol on the expression of HPV E6 and p53 in cervical carcinoma cells. | 2015 |
|
| Dietary supplements for benign prostatic hyperplasia: an overview of systematic reviews. | 2012-11 |
|
| Beta-sitosterol, a plant sterol, induces apoptosis and activates key caspases in MDA-MB-231 human breast cancer cells. | 2003-02-13 |
|
| Beta-sitosterols for benign prostatic hyperplasia. | 2000 |
|
| The influence of beta-sitosterol on biliary cholesterol saturation and bile acid kinetics in man. | 1978 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/345413
Over 6 to 8 weeks beta-sitosterol supplementation of 12 g/day resulted in an average of 11% decrease in serum cholesterol and a 12% decrease in biliary cholesterol saturation.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26199569
Human cervical cancer cell lines, Caski and HeLa, were cultured in RPMI-1640 and supplemented with 10% foetal bovine serum and incubated at 37 deg-c in an atmosphere with 5% CO2. Cells were treated with 20 umol/L of beta-sitosterol for 48 hours and examined for changes by light microscopy, electron microscopy, and transmission electron microscopy. Changes in mRNA and protein expression were quantified using Real-Time qPCR and western blots. The treatment with beta-sitosterol reduced expression of PCNA, increased p53 mRNA, decreased the amount of HPV E6 transcripts. Cells treated with beta-sitosterol also exhibited loss of cell surface microvilli and increased electron density in the cell membrane.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:46:17 GMT 2025
by
admin
on
Mon Mar 31 17:46:17 GMT 2025
|
| Record UNII |
S347WMO6M4
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DSLD |
1062 (Number of products:256)
Created by
admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
|
||
|
NCI_THESAURUS |
C68437
Created by
admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
|
||
|
LOINC |
75741-9
Created by
admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
|
||
|
DSLD |
2256 (Number of products:9)
Created by
admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
83-46-5
Created by
admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
|
PRIMARY | |||
|
18173
Created by
admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
|
PRIMARY | |||
|
BETA-SITOSTEROL
Created by
admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
|
PRIMARY | |||
|
222284
Created by
admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
|
PRIMARY | |||
|
15764-35-9
Created by
admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
|
SUPERSEDED | |||
|
5779-62-4
Created by
admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
182512-23-8
Created by
admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
|
SUPERSEDED | |||
|
100000090258
Created by
admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
|
PRIMARY | |||
|
DB14038
Created by
admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
|
PRIMARY | |||
|
47070
Created by
admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
|
PRIMARY | RxNorm | ||
|
8096
Created by
admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
|
PRIMARY | |||
|
S347WMO6M4
Created by
admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
|
PRIMARY | |||
|
SUB27060
Created by
admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
|
PRIMARY | |||
|
27693
Created by
admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
|
PRIMARY | |||
|
m9964
Created by
admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
|
PRIMARY | Merck Index | ||
|
8003-23-4
Created by
admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
|
SUPERSEDED | |||
|
201-480-6
Created by
admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
|
PRIMARY | |||
|
C63662
Created by
admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
|
PRIMARY | |||
|
S347WMO6M4
Created by
admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
|
PRIMARY | |||
|
49083
Created by
admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
|
PRIMARY | |||
|
76772-70-8
Created by
admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
|
SUPERSEDED | |||
|
DTXSID5022481
Created by
admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
|
PRIMARY | |||
|
1612947
Created by
admin on Mon Mar 31 17:46:18 GMT 2025 , Edited by admin on Mon Mar 31 17:46:18 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
CALENDULA OFFICINALIS FLOWER terpenoid
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|